Skip to content
10-Q

Quarterly Report

Longboard Pharmaceuticals, Inc.

0000950170-24-089319

← back to feed
Filed
Aug 1, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 30, 2024 38.9M sh
Shares Diluted Q2 2024 · Jun 30, 2024 38.88M sh
Shares Diluted Q2 2024 · Jun 30, 2024 37.1M sh
Shares Diluted Q2 2024 · Jun 30, 2023 22.97M sh
Shares Diluted Q2 2024 · Jun 30, 2023 21.7M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$34.31M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$26.55M
Short Term Investments Q2 2024 · Jun 30, 2024 $290.27M
Short Term Investments Q2 2024 · Dec 31, 2023 $34.17M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $14.6M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $14.33M
Stockholders Equity Q2 2024 · Jun 30, 2024 $294.6M
Stockholders Equity Q2 2024 · Mar 31, 2024 $313.71M
Stockholders Equity Q2 2024 · Dec 31, 2023 $40.92M
Stockholders Equity Q2 2024 · Jun 30, 2023 $58.11M
Stockholders Equity Q2 2024 · Mar 31, 2023 $72.13M
Stockholders Equity Q2 2024 · Dec 31, 2022 $61.47M
Current Liabilities Q2 2024 · Jun 30, 2024 $14.74M
Current Liabilities Q2 2024 · Dec 31, 2023 $9.77M
Current Assets Q2 2024 · Jun 30, 2024 $308.81M
Current Assets Q2 2024 · Dec 31, 2023 $50.22M
Total Assets Q2 2024 · Jun 30, 2024 $312.91M
Total Assets Q2 2024 · Dec 31, 2023 $50.7M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.56
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.99
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.65
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.22
Eps Basic Q2 2024 · Jun 30, 2024 −$0.56
Eps Basic Q2 2024 · Jun 30, 2024 −$0.99
Eps Basic Q2 2024 · Jun 30, 2023 −$0.65
Eps Basic Q2 2024 · Jun 30, 2023 −$1.22
Sga Expense Q2 2024 · Jun 30, 2024 $5.2M
Sga Expense Q2 2024 · Jun 30, 2024 $10.14M
Sga Expense Q2 2024 · Jun 30, 2023 $3.11M
Sga Expense Q2 2024 · Jun 30, 2023 $6.54M
Rd Expense Q2 2024 · Jun 30, 2024 $20.45M
Rd Expense Q2 2024 · Jun 30, 2024 $33.62M
Rd Expense Q2 2024 · Jun 30, 2023 $12.54M
Rd Expense Q2 2024 · Jun 30, 2023 $21.07M
Net Income Q2 2024 · Jun 30, 2024 −$21.79M
Net Income Q2 2024 · Jun 30, 2024 −$36.77M
Net Income Q2 2024 · Mar 31, 2024 −$14.99M
Net Income Q2 2024 · Jun 30, 2023 −$15M
Net Income Q2 2024 · Jun 30, 2023 −$26.46M
Net Income Q2 2024 · Mar 31, 2023 −$11.46M
Operating Income Q2 2024 · Jun 30, 2024 −$25.64M
Operating Income Q2 2024 · Jun 30, 2024 −$43.75M
Operating Income Q2 2024 · Jun 30, 2023 −$15.64M
Operating Income Q2 2024 · Jun 30, 2023 −$27.6M